Back to Journals » OncoTargets and Therapy » Volume 9

Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors

Total article views   HTML views PDF downloads Totals
16,661 Dovepress* 7,981+ 1,371 9,352
PubMed Central* 8,680 1,017 9,697
Totals 16,661 2,388 19,049
*Since 9 February 2016
+Since July 2016

View citations on PubMed Central and Google Scholar